Indications, Labeling, and Outcomes Assessment for Drugs Aimed at Improving Functional Status in Older Persons: A Conversation Between Aging Researchers and FDA Regulators

被引：19

作者：

Bhasin, Shalender ^{[1
]}

Espeland, Mark A. ^{[2
]}

Evans, William J. ^{[3
]}

Ferrucci, Luigi ^{[4
]}

Fried, Linda P. ^{[5
]}

Gill, Thomas M. ^{[6
]}

Pahor, Marco ^{[7
]}

Studenski, Stephanie ^{[8
]}

Guralnik, Jack ^{[9
]}

Nayfi, Susan ^{[10
]}

Romashkin, Sergei ^{[10
]}

Perlstein, Robert ^{[11
]}

Burke, Laurie ^{[11
]}

Parks, Mary ^{[11
]}

机构：

[1] Boston Univ, Sch Med, Boston, MA 02215 USA

[2] Wake Forest Univ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA

[3] Univ Arkansas Med Sci, Donald W Reynolds Inst Aging, Little Rock, AR 72205 USA

[4] NIA, Baltimore Longitudinal Study Aging, Bethesda, MD 20892 USA

[5] Cornell Univ, Ithaca, NY 14853 USA

[6] Yale Univ, Sch Med, New Haven, CT 06520 USA

[7] Univ Florida, Sch Med, Gainesville, FL 32611 USA

[8] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA

[9] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA

[10] NIA, Geriatr & Clin Gerontol Program, Bethesda, MD 20892 USA

[11] US FDA, Rockville, MD 20857 USA

来源：

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | 2009年 / 64卷 / 04期

关键词：

MUSCLE MASS SARCOPENIA; SKELETAL-MUSCLE; POSTMENOPAUSAL WOMEN; BODY-COMPOSITION; FRAILTY; STRENGTH; MEN; DISABILITY; CARE; OSTEOPOROSIS;

D O I：

10.1093/gerona/gln042

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

[No abstract available]

引用

页码：487 / 491

页数：5